Variants in APOA5 are associated with triglyceride levels, diseases involving lipid traits, CAD, total cholesterol levels, and metabolic syndrome (Kettunen et al., 2012; Zhou et al., 2013; van der Harst and Verweij, 2018). This evidence concerns the gene APOA5 and metabolic syndrome.